Why Pfizer (PFE) Stock Is Down Today

NEW YORK (TheStreet) -- Pfizer  (PFE) continued to dip Wednesday after British Prime Minister David Cameron told the U.S. pharmaceutical giant it must provide stronger guarantees it would keep jobs and investment in the U.K. in order to acquire the British government's support to take over AstraZeneca  (AZN).

Late last week, AstraZeneca rejected Pfizer's third takeover bid of $106 billion. Such an acquisition would be the largest takeover of a British firm in history. But Cameron hinted Wednesday the British government could intervene in the purchase should it happen.

The stock was down 1.7% to $28.93 at 3:08 p.m.
PFE Chart

PFE data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux